Evome Medical Technologies, Inc. Restricted Cash
Evome Medical Technologies, Inc. had Restricted Cash of CAD 1.35 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Restricted Cash and Investments › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2023-05-15
- 2023-03-31: Restricted Cash 1.35M CAD.
- 2022-12-31: Restricted Cash 0.00 CAD.
- 2022-02-28: Restricted Cash 0.00 CAD.
- 2021-11-30: Restricted Cash 0.00 CAD.
| Period end | Restricted Cash |
|---|---|
| 2023-03-31 | 1.35M CAD 10-Q · filed 2023-05-15 |
| 2022-12-31 | 0.00 CAD 10-Q · filed 2023-05-15 |
| 2022-02-28 | 0.00 CAD 10-K · filed 2022-05-31 |
| 2021-11-30 | 0.00 CAD 10-Q · filed 2022-01-14 |
| 2021-08-31 | 0.00 CAD 10-Q · filed 2021-10-15 |
| 2021-05-31 | 889.47K CAD 10-Q/A · filed 2021-08-02 |
| 2021-02-28 | 5.43M CAD 10-K · filed 2022-05-31 |